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doi:10.1016/j.jmii.2010.04.003Background: We aim to evaluate the efficacy of polymerase chain reaction (PCR) to detect Aci-
netobacter baumannii in endotracheal aspirates.
Methods: Endotracheal aspirates and clinical data were collected from patients who were
admitted to the intensive care unit of Taipei Veterans General Hospital between April 1 and
August 31 in 2006. Bacterial isolates from endotracheal aspirate cultures were phenotypically
identified as Acinetobacter calcoaceticuseA baumannii complex using the API ID 32GN
system. The presence of A baumannii in the aspirate was also directly detected by multiplex
PCR.
Results: Ten of the 114 endotracheal aspirate cultures were positive for A calcoaceticuse
A baumannii complex, and only nine of the isolates were confirmed as A baumannii by the
multiplex PCR. Direct PCR detection showed that 40 (35.1%) of the endotracheal aspirates
were positive for A baumannii. Using positive culture of A baumannii as the gold standard,
the sensitivity of direct PCR detection was 100% (6 of 6), the specificity was 70.4% (38 of
54), the positive predictive value was 27.3% (6 of 22), and the negative predictive value
(NPV) was 100% (38 of 38) among patients with A baumannii pneumonia. Among patients with
A baumannii colonization, the sensitivity of direct PCR detection was 100% (3 of 3), theInfectious Diseases, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2,
v.tw (T.-L. Chen).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
PCR detection of Acinetobacter baumannii in endotracheal aspirates 107specificity was 70.6% (36 of 51), the positive predictive value was 16.7% (3 of 18), and the NPV
was 100% (36 of 36).
Conclusion: Direct PCR detection of A baumannii in endotracheal aspirates has a high
sensitivity and NPV as compared with culture-based methods. Further studies are needed to
determine the clinical applicability of this rapid detection test.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
In the last decade, Acinetobacter baumannii has become
an increasingly important cause of nosocomial infection,
particularly ventilator-associated pneumonia, in intensive
care units (ICUs).1 The risk factors for ventilator-associated
pneumonia because of A baumannii include a longer
hospital stay, longer time on ventilation, prior episodes of
sepsis, reintubation, and prior antibiotic use.1 The diag-
nosis of A baumannii pneumonia is usually based on the
symptoms of respiratory tract infection in addition to the
analysis of radiographic and microbiologic data.2
The culture of specimens from the lower respiratory
tract has been the most important diagnostic method for
respiratory tract infections.3 However, it takes time for the
culture results to become available. The bacterial growth
may also be inhibited because of the prior administration
of empirical antibiotics, thus yielding false-negative
culture results. Early detection of the causative pathogen
can help the physician to prescribe appropriate antimi-
crobial agents, which may lead to a better prognosis of the
patients. The polymerase chain reaction (PCR) has been
adopted to detect the pathogens of respiratory tract
infections over the last few years.4 PCR on a single throat
swab specimen may greatly simplify the diagnosis of
lower respiratory tract infections caused by Legionella
spp., Mycoplasma pneumoniae, or Chlamydia pneumo-
niae,5 and it also plays an important role in the diagnosis
of Mycobacterium tuberculosis.6 To our knowledge, there
is no current report detailing the efficacy of PCR in the
direct detection of A baumannii from respiratory tract
samples. The aim of this study was to evaluate the efficacy
of using PCR to detect A baumannii from endotracheal
aspirates.Materials and methods
Specimen collection and study design
Endotracheal aspirates were prospectively and consecu-
tively collected from patients admitted to the medical ICU
of the Taipei Veterans General Hospital, who received
endotracheal intubation and mechanical ventilation from
April 1 to August 31, 2006. Each specimen was collected
from the endotracheal tube using a sterile suction tube.
The clinical data were prospectively collected and insured
by the institutional review board. This was an observational
study, and the management of the patients (including
antimicrobial therapy) was not influenced by the results of
the analysis.Phenotypic and genotypic identification of
Acinetobacter isolates
All the aspirated specimens were sent for bacterial
culture. Isolates recovered from culture were subjected to
phenotypic identification using the API ID 32GN system
(bioMerieux, Marcy l’Etoile, France). Those specimens
identified as Acinetobacter calcoaceticuseA baumannii
complex were further identified to the genomic species
level as A baumannii using a multiplex PCR method.7 This
PCR method included two pairs of primers. The first pair of
primers, P-Ab-ITSF (50-CATTATCACGGTAATTAGTG-30) and P-
Ab-ITSB (50-AGAGCACTGTGCACTTAAG-30), specifically
amplified an internal 208-bp fragment of the 16S-23S ribo-
somal DNA intergenic spacer region of A baumannii. The
second pair of primers, P-rA1 (50-CCTGAATCTTCTGGTAA
AAC-30) and P-rA2 (50-GTTTCTGGGCTGCCAAACATTAC-30),
which targeted a highly conserved region of the recA gene
(about 425 bp) of Acinetobacter spp., was included as
a reaction control. The reaction produced two bands if the
bacteria were A baumannii, whereas only one band corre-
sponding to the recA gene was seen if the bacteria were
other Acinetobacter spp. Isolates identified as Acineto-
bacter spp. other than A baumannii were further identified
to the genomic species level using 16S-23S ribosomal
DNA intergenic spacer sequence analysis as described
previously.7
For direct identification of A baumannii from the
endotracheal aspirates, the samples were first submitted
to a process of digestion and decontamination with 4%
NaOH.8 The specimens were then subjected to gene
extraction using a PureGene DNA Purification kit (Gentra
Systems, Minneapolis, MN, USA). The purified DNA was
then used as a template in the multiplex PCR for identi-
fication of A baumannii using the same aforementioned
primers and protocol. The results were available within
4 hours.
Definition of pneumonia
Pneumonia was defined as follows: (1) patients had one
or more serial chest X-rays with one of the following: new
infiltrate, progressive infiltrate, or consolidation; (2)
patients had at least one of the following: fever (>38C)
without other causes, leukopenia (<4,000 WBC/mL) or
leukocytosis (12,000 WBC/mL), or altered mental status
without other causes (in patients 70 years old); and (3)
patients had at least two of the following: new onset of
purulent sputum (or change in character of sputum,
increasing respiratory secretions, or increasing suctioning
requirements); new onset of worsening cough (or dyspnea,
108 M.-C. Chiang et al.tachypnea, rales, or bronchial breath sounds); or worsening
gas exchange.9 Acinetobacter baumannii pneumonia was
defined as evidence of pneumonia in addition to culture
from the endotracheal aspirate yielding only A baumannii.
The colonization of A baumannii was defined as having
a positive A baumannii culture from endotracheal aspirate
without evidence of pneumonia. The Acute Physiology and
Chronic Health Evaluation II score was used as previously
defined.10
Statistical analysis
Analyses were performed using the SPSS statistical software
(version 15.0; SPSS, Chicago, IL, USA). Qualitative variables
were compared using the Pearson Chi-square test or
Fisher’s exact test. A p value less than 0.05 was considered
statistically significant.
Results
Patient characteristics
A total of 114 patients were enrolled in this study, and 81 of
them were men. Their age ranged from 17 to 97 years, with
an average age of 70.7 years. The underlying diseases of
the patients are listed in Table 1. Most of the patients had
at least one underlying disease and were critically ill, with
a mean Acute Physiology and Chronic Health Evaluation II
score of 20.86 7.02. The API ID 32GN system revealed that
10 of the 114 cultures were positive for A calcoaceticuseA
baumannii complex. However, one of the isolates was
identified by the genotypic method as Acinetobacter
genomic species 13TU. Therefore, only nine patients had
positive culture results for A baumannii. Direct PCR
detection of A baumannii showed that 40 (35.1%) of the 114
patients were positive, whereas 74 (64.9%) demonstrated
negative PCR results in their endotracheal aspirates. The
comparison of the underlying diseases between the
patients with positive and negative PCR results showed that
only hematological malignancy was significantly more
prevalent among the patients positive for A baumannii
(Table 2).Table 1 The underlying diseases of the patients (nZ 114)
Underlying diseases n (%)
Hypertension 49 (43)
Operation within 1 mo 41 (36.0)
Solid tumor 37 (32.5)
Type 2 diabetes mellitus 35 (30.7)
Shock 20 (17.5)
Cerebral vascular disease 18 (15.8)
Coronary artery disease 13 (11.4)
Chronic renal failure 13 (11.4)
Chronic obstructive pulmonary disease 12 (10.5)
Liver cirrhosis 8 (7.0)
Hematological malignancy 6 (5.3)
Collagen vascular disease 4 (3.5)The efficacy of direct PCR detection in patients
with Acinetobacter baumannii pneumonia
Among the patients included in our study, 60 had pneu-
monia. Among them, six (10%) had a diagnosis of A bau-
mannii (initially identified by API ID 32GN, then confirmed
by PCR) pneumonia, whereas 22 (36.7%) had positive results
by means of direct PCR detection. Using those samples with
a positive culture for A baumannii as a standard, the
sensitivity of direct PCR detection was 100% (6 of 6), the
specificity was 70.4% (38 of 54), the positive predictive
value was 27.3% (6 of 22), and the negative predictive value
was 100% (38 of 38), as shown in Table 3. There was no
significant difference regarding the underlying diseases
between patients with positive and negative PCR results.
There was also no significant difference regarding the in-
hospital mortality rate, 14-day mortality (since ICU admis-
sion), or the length of hospital stay (Table 4).
The efficacy of direct PCR detection in patients
with Acinetobacter baumannii colonization
Among the 114 patients, 54 patients revealed no evidence
of pneumonia. Among these 54 patients, 18 had positive
PCR results and 36 had negative results for A baumannii.
Using positive culture of A baumannii as a standard, the
sensitivity of direct PCR detection was 100% (3 of 3), the
specificity was 70.6% (36 of 51), the positive predictive
value was 16.7% (3 of 18), and the negative predictive value
was 100% (36 of 36). There was also no significant differ-
ence regarding the underlying diseases and outcomes
between the patients with positive and negative PCR
results in this group (Table 4).
Discussion
The intravascular space and respiratory tract are the two
most common sources of A baumannii bacteremia, and both
are associated with a high mortality rate.11,12 The early
diagnosis of A baumannii pneumonia with prompt applica-
tion of appropriate therapy may prevent systemic involve-
ment. The time required for the identification of
A baumannii based on culture methods is at least 3 days.
PCR is a method that combines rapid nucleic acid extrac-
tion, amplification, and detection.13 The time for microbi-
ological identification using multiplex PCR can be as short
as 3e4 hours, which greatly improves the turnaround
time.14 Although PCR has been applied for the diagnosis of
a diverse range of respiratory pathogens,15 our study is the
first prospective observational study to evaluate the clin-
ical utility of PCR on specimens from the respiratory tract
for the detection of A baumannii.
Among patients with pneumonia, our study demon-
strated the high sensitivity and negative predictive value of
direct PCR detection for determination of A baumannii.
However, the application of PCR was limited by the low
positive predictive value, which might be because of the
following possibilities. First, negative culture results could
have been obscured by prior antimicrobial therapy, which
was applied when pneumonia was first suspected. As such,
the dead bacterial remnants would fail to grow on culture
Table 2 Comparison of underlying diseases between patients with positive and negative results by means of direct PCR
detection of Acinetobacter baumannii in endotracheal aspirates
Underlying diseases PCR () (nZ 74) PCR (þ) (nZ 40) p
Hypertension 32 (43.2) 17 (42.5) 1.000
Type 2 diabetes mellitus 22 (29.7) 13 (32.5) 0.926
Liver cirrhosis 7 (9.5) 1 (2.5) 0.257
Operation within 1 mo 28 (37.8) 13 (32.5) 0.717
Shock 13 (17.6) 7 (17.5) 1.000
Solid tumor 27 (36.5) 10 (26.0) 0.298
Hematological malignancy 1 (1.4) 5 (12.5) 0.02
Cerebral vascular disease 12 (16.2) 6 (15.0) 1.000
Coronary artery disease 6 (8.1) 7 (17.5) 0.215
Chronic obstructive pulmonary disease 6 (8.1) 6 (15.0) 0.339
Chronic renal failure 10 (13.5) 3 (7.5) 0.538
Collagen vascular disease 2 (2.7) 2 (5.0) 0.611
Data are presented as n(%).
PCRZ polymerase chain reaction.
PCR detection of Acinetobacter baumannii in endotracheal aspirates 109plates but could be detected by PCR. Second, the more
sensitive nature of PCR detection might lead to the
detection of a small number of A baumannii, which might
not be detected in culture or be outgrown by the other
bacteria present in the aspirate sample. Third, the PCR
results might be attributed to a false positive. However, the
inclusion of a negative PCR control minimized this possi-
bility. Fourth, the more sensitive PCR method might detect
a small number of A baumannii, that is, however, not the
responsible agent for the pneumonia.
Despite the rapid detection of A baumannii by PCR,
there was no difference regarding the outcome between
the patients with positive and negative PCR results. A
possible reason for this observation was that patients from
both groups had comparable underlying diseases and were
both critically ill. Moreover, this was an observational
study, and no change in intervention occurred after a posi-
tive result. Because most of the A baumannii isolates were
multidrug resistant, it is essential to determine whetherTable 3 The comparison of direct PCR detection and
phenotypic identification in addition to PCR verification of
A baumannii among patients with A baumannii pneumonia
or colonization
Direct PCR detection, n
() (þ)
A baumannii pneumonia
Culture (þ)a 0 6
Culture ()a 38 16
Total 38 22
A baumannii colonization
Culture (þ)a 0 3
Culture ()a 36 15
Total 36 18
a The genomic species A baumannii identified by the culture
method was initially identified using the API ID 32GN system and
then further verified by PCR.
A baumanniiZ Acinetobacter baumannii; PCRZ polymerase
chain reaction.a prompt change in antibiotic treatment after a positive
PCR result would improve a patient’s outcome. The high
negative predictive value of PCR in the diagnosis of
A baumannii pneumonia might help to limit the prescription
of unnecessary broad-spectrum antibiotics for those
patients with negative PCR results. On the other hand,
before a more comprehensive prospective study is con-
ducted to elucidate the clinical significance of positive PCR
results in pneumonic patients who have negative culture
results, there should be an awareness of the overestimation
of the significance of the PCR detection to avoid overuse of
broad-spectrum antibiotics.
The PCR detection of A baumannii in patients without
evidence of pneumonia was most likely because of A bau-
mannii colonization. Acinetobacter baumannii can be part
of the bacterial flora of the human body,16 and the respi-
ratory tract is an important site of colonization.17 Acine-
tobacter baumannii colonization has been reported in the
nasopharynx and other sites of the respiratory tract.18 In
the evaluation of A baumannii colonization, direct PCR
detection also demonstrated a high sensitivity and high
negative predictive value. In this study, because of the
small number of patients, we did not determine whether
PCR detection of A baumannii colonization could predictTable 4 The comparison of outcomes between patients
with positive and negative PCR results
Outcome p
PCR () PCR (þ)
Pneumonia group
14-d mortality 8/38 1/22 0.135
In-hospital mortality 17/38 9/22 0.986
Length of hospital stay (d) 46.42 40 51.64 31 0.582
Colonization group
14-d mortality 5/36 5/18 0.273
In-hospital mortality 14/36 11/18 0.210
Length of hospital stay (d) 41.53 42 49.44 56 0.817
PCRZ polymerase chain reaction.
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negative predictive value of PCR detection of A baumannii
colonization might implicate a role for this method in
outbreak control in ICUs or nursing institutions. The rapid
nature and high negative predictive value of PCR detection
might be used to identify individuals who need to be iso-
lated during an A baumannii outbreak.
Despite the promising preliminary results, there are
limitations to our study. Gram stain was not used to check
the quality of the aspirates, and it might be difficult to
distinguish real infections from colonization, even when
positive culture results and a pulmonary infiltrate were
obtained. Gram stain is a dependent diagnostic test for the
early etiological diagnosis of bacterial pneumonia.19 To
yield a reliable microbial etiology during the early diagnosis
of A baumannii pneumonia that will prevent overuse of
antibiotics, a prospective study that uses PCR combined
with Gram stain verification or even invasive diagnostic
methods20 might be warranted.
In conclusion, our study demonstrated that direct PCR
detection for the early identification of A baumannii from
endotracheal aspirates was fast and had a high sensitivity
and negative predictive value. Further study is required to
explore the potential role of this approach in the diagnosis
of A baumannii pneumonia and outbreak control.
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